Michael Gunnar Knell, SVP, Finance and Chief Accounting Officer of Charles River Laboratories International, Inc., filed a Form 4 on November 9, 2026, disclosing a disposition of 649 shares of common stock on November 6, 2026, to satisfy tax withholding obligations tied to the vesting of restricted stock units.
Key Highlights
- Reporting person: Michael Gunnar Knell, SVP, Finance and CAO at Charles River Laboratories International, Inc. (NYSE:CRL)
- Transaction date: November 6, 2026
- Shares disposed: 649 shares of common stock withheld at a price of $313.02 per share
- Transaction code: F, representing shares withheld by the issuer for tax withholding on RSU vesting
- Beneficial ownership following transaction: 11,203 shares of common stock, held directly
- No derivative securities were reported as acquired, disposed of, or beneficially owned in this filing
RSU Tax Withholding Transaction Details for Knell at Charles River Laboratories
According to the filing, Knell disposed of 649 shares of Charles River Laboratories International, Inc. common stock on November 6, 2026, at a per-share price of $313.02. The filing states that these shares represent stock "withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units." The transaction is recorded under transaction code F, which denotes shares withheld by the issuer rather than an open-market sale.
Following this transaction, the filing reports that Knell directly beneficially owns 11,203 shares of the company's common stock. No indirect ownership or derivative securities positions were reported. The Form 4 was signed by Heather Turner as attorney-in-fact for Michael G. Knell and filed on November 9, 2026. The filing indicates that Knell holds the title of SVP, Finance and CAO and is classified as an officer of the issuer.
The filing notes that the transaction was not indicated as being made pursuant to a Rule 10b5-1(c) plan. No other transactions were reported in Table I or Table II of the form.
What Was Disclosed
The filing disclosed a single disposition of 649 shares of common stock by Charles River Laboratories' SVP, Finance and CAO, Michael Gunnar Knell, on November 6, 2026, at $313.02 per share, solely to cover tax obligations on vesting restricted stock units, leaving him with 11,203 shares directly owned.





Please wait processing your request...